Prediction of high-degree steroid dependency in pediatric idiopathic nephrotic syndrome
- PMID: 18618150
- DOI: 10.1007/s00467-008-0914-y
Prediction of high-degree steroid dependency in pediatric idiopathic nephrotic syndrome
Abstract
Most patients with idiopathic nephrotic syndrome are steroid-responsive, but about 50% relapse and often become steroid-dependent and exposed to long-term steroid complications. The aim of this study was to determine predictive risk factors for steroid and/or cyclosporine A (CyA) dependence. In France, steroid responsiveness is defined as remission after 1 month of oral prednisone (60 mg/m(2) per day) and-in the case of persistent proteinuria on day 30-three methylprednisolone pulses (MPP; 1 g/1.73 m(2) on days 1, 3, and 5). Thirty-five steroid-responsive children, followed between 1999 and 2006, were included in this study. Median age at diagnosis was 4.9 years. All patients initially received prednisone 60 mg/m(2) per day. Twenty-four of the 35 patients were steroid-dependent, with 12 requiring MPP. Of the latter 12 patients, 83.3% were treated with CyA during follow-up; in comparison, only 16.7% of the patients who did not receive MPP required CyA during follow-up (chi-square test, P = 0.001). T risk for steroid dependence was 100% in our cohort if remission was achieved after day 20. Patients who need MPP are at high risk to require CyA to achieve disease control. By identifying these children, we could use adequate immunosuppressive drugs earlier and reduce morbidity related to steroids and multiple relapses.
Similar articles
-
Cyclosporin A plus prednisone treatment of steroid-sensitive frequently relapsing nephrotic syndrome in children.Turk J Pediatr. 1999 Apr-Jun;41(2):225-30. Turk J Pediatr. 1999. PMID: 10770662 Clinical Trial.
-
Efficacy of steroids, cyclosporin and cyclophos-phamide in steroid resistant idiopathic nephrotic syndrome.J Coll Physicians Surg Pak. 2005 Jun;15(6):329-32. J Coll Physicians Surg Pak. 2005. PMID: 15924835
-
Remission of steroid- and CyA-resistant nephrotic syndrome using multiple drug immunosuppression.Pediatr Nephrol. 2007 Oct;22(10):1723-6. doi: 10.1007/s00467-007-0551-x. Epub 2007 Jul 17. Pediatr Nephrol. 2007. PMID: 17636340
-
Treatment of the idiopathic nephrotic syndrome: regimens and outcomes in children and adults.J Am Soc Nephrol. 1997 May;8(5):824-32. doi: 10.1681/ASN.V85824. J Am Soc Nephrol. 1997. PMID: 9176855 Review.
-
Pediatric idiopathic nephrotic syndrome: treatment strategies in steroid dependent and steroid resistant forms.Curr Med Chem. 2010;17(9):847-53. doi: 10.2174/092986710790712174. Curr Med Chem. 2010. PMID: 20156172 Review.
Cited by
-
Steroid-sensitive nephrotic syndrome in children: triggers of relapse and evolving hypotheses on pathogenesis.Ital J Pediatr. 2015 Mar 21;41:19. doi: 10.1186/s13052-015-0123-9. Ital J Pediatr. 2015. PMID: 25888239 Free PMC article. Review.
-
Time to remission in childhood steroid sensitive nephrotic syndrome: a change in perspective.Eur J Pediatr. 2025 Mar 20;184(4):262. doi: 10.1007/s00431-025-06090-z. Eur J Pediatr. 2025. PMID: 40111516 Free PMC article.
-
Prediction of steroid-sparing agent use in childhood idiopathic nephrotic syndrome.Pediatr Nephrol. 2013 Apr;28(4):631-8. doi: 10.1007/s00467-012-2365-8. Epub 2012 Nov 21. Pediatr Nephrol. 2013. PMID: 23179197
-
Timing of relapse as a key indicator of steroid-sparing requirements in childhood idiopathic nephrotic syndrome.J Nephrol. 2024 Dec;37(9):2551-2559. doi: 10.1007/s40620-024-02076-6. Epub 2024 Sep 1. J Nephrol. 2024. PMID: 39218996
-
Steroid pulse therapy in idiopathic nephrotic syndrome in the era of modern immunosuppressive treatment-still up to date?Pediatr Nephrol. 2025 Feb;40(2):417-422. doi: 10.1007/s00467-024-06535-x. Epub 2024 Sep 24. Pediatr Nephrol. 2025. PMID: 39316153
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical